awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q39175455-F07D343E-B04A-4866-BDB5-332FE93EAE69
Q39175455-F07D343E-B04A-4866-BDB5-332FE93EAE69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39175455-F07D343E-B04A-4866-BDB5-332FE93EAE69
Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).
P2860
Q39175455-F07D343E-B04A-4866-BDB5-332FE93EAE69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39175455-F07D343E-B04A-4866-BDB5-332FE93EAE69
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cb827c3f9bb96f280c4a97dcb8b864b3222fd17
P2860
Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation